{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:34:01Z","timestamp":1793381641352,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.peptides.2022.170786","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T21:22:34Z","timestamp":1647379354000},"page":"170786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Fibroblast growth factor 12 attenuated cardiac remodeling via suppressing oxidative stress"],"prefix":"10.1016","volume":"153","author":[{"given":"Aijun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shucan","family":"Xun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.peptides.2022.170786_bib1","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s10741-020-09979-z","article-title":"Clinical inertia in the treatment of heart failure: a major issue to tackle","volume":"26","author":"Verhestraeten","year":"2021","journal-title":"Heart Fail. Rev."},{"issue":"1","key":"10.1016\/j.peptides.2022.170786_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCRESAHA.120.317685","article-title":"Multiscale analysis of extracellular matrix remodeling in the failing heart","volume":"128","author":"Perestrelo","year":"2021","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.peptides.2022.170786_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021120","article-title":"Therapeutic stalemate in heart failure with preserved ejection fraction","volume":"10","author":"Samson","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.peptides.2022.170786_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174472","article-title":"1, 8-cineole protects against ISO-induced heart failure by inhibiting oxidative stress and ER stress in vitro and in vivo","volume":"910","author":"Wang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.peptides.2022.170786_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10741-018-9720-1","article-title":"Biomarkers for the identification of cardiac fibroblast and myofibroblast cells","volume":"24","author":"Tarbit","year":"2019","journal-title":"Heart Fail. Rev."},{"issue":"24","key":"10.1016\/j.peptides.2022.170786_bib6","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.7150\/thno.33920","article-title":"LncRNA-Safe contributes to cardiac fibrosis through Safe-Sfrp2-HuR complex in mouse myocardial infarction","volume":"9","author":"Hao","year":"2019","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.peptides.2022.170786_bib7","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/liv.14863","article-title":"Role of fibroblast growth factor signalling in hepatic fibrosis","volume":"41","author":"Seitz","year":"2021","journal-title":"Liver Int."},{"issue":"7","key":"10.1016\/j.peptides.2022.170786_bib8","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1681\/ASN.2020010081","article-title":"A land of controversy: fibroblast growth factor-23 and uremic cardiac hypertrophy","volume":"31","author":"Bao","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.peptides.2022.170786_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.672935","article-title":"The multifunctional contribution of FGF signaling to cardiac development, homeostasis, disease and repair","volume":"9","author":"Khosravi","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.peptides.2022.170786_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.745892","article-title":"Cardiac fibroblast growth factor 23 excess does not induce left ventricular hypertrophy in healthy mice","volume":"9","author":"Leifheit-Nestler","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.peptides.2022.170786_bib11","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.bbadis.2019.01.019","article-title":"Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1","volume":"1865","author":"Li","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"6","key":"10.1016\/j.peptides.2022.170786_bib12","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1161\/HYPERTENSIONAHA.120.15068","article-title":"FGF12 (Fibroblast Growth Factor 12) inhibits vascular smooth muscle cell remodeling in pulmonary arterial hypertension","volume":"76","author":"Yeo","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2022.170786_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173279","article-title":"Low-dose hydralazine improves endotoxin-induced coagulopathy and multiple organ dysfunction via its anti-inflammatory and anti-oxidative\/nitrosative properties","volume":"882","author":"Huang","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2022.170786_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174402","article-title":"Apocynin attenuates diabetic cardiomyopathy by suppressing ASK1-p38\/JNK signaling","volume":"909","author":"Ding","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.peptides.2022.170786_bib15","doi-asserted-by":"crossref","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","article-title":"Oxidative stress and heart failure","volume":"301","author":"Tsutsui","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.peptides.2022.170786_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ejhf.1320","article-title":"Treating oxidative stress in heart failure: past, present and future","volume":"21","author":"van der Pol","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.peptides.2022.170786_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fendo.2015.00133","article-title":"FGF21 and cardiac physiopathology","volume":"6","author":"Planavila","year":"2015","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.peptides.2022.170786_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fphys.2013.00247","article-title":"Pathophysiological roles of FGF signaling in the heart","volume":"4","author":"Itoh","year":"2013","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.peptides.2022.170786_bib19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/2047487319870344","article-title":"Oxidative stress and inflammation in the evolution of heart failure: from pathophysiology to therapeutic strategies","volume":"27","author":"Aimo","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"10","key":"10.1016\/j.peptides.2022.170786_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101627","article-title":"FGF13 is a novel regulator of NF-kappaB and potentiates pathological cardiac hypertrophy","volume":"23","author":"Sun","year":"2020","journal-title":"iScience"},{"issue":"5","key":"10.1016\/j.peptides.2022.170786_bib21","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1002\/ehf2.12816","article-title":"Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction","volume":"7","author":"Roy","year":"2020","journal-title":"ESC Heart Fail."},{"issue":"6","key":"10.1016\/j.peptides.2022.170786_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MED.0000000000000294","article-title":"FGF-23 and cardiovascular disease: review of literature","volume":"23","author":"Batra","year":"2016","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"8","key":"10.1016\/j.peptides.2022.170786_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006130","article-title":"De Novo FGF12 (Fibroblast Growth Factor 12) functional variation is potentially associated with idiopathic ventricular tachycardia","volume":"6","author":"Li","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.peptides.2022.170786_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12967-015-0510-4","article-title":"Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling","volume":"13","author":"Svystonyuk","year":"2015","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.peptides.2022.170786_bib25","first-page":"1630","article-title":"FGF-16 protects against adverse cardiac remodeling in the infarct diabetic heart","volume":"9","author":"Hu","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"7","key":"10.1016\/j.peptides.2022.170786_bib26","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/gtc.12055","article-title":"Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16","volume":"18","author":"Matsumoto","year":"2013","journal-title":"Genes Cells"},{"issue":"1","key":"10.1016\/j.peptides.2022.170786_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.repc.2015.09.006","article-title":"Statins and oxidative stress in chronic heart failure","volume":"35","author":"Costa","year":"2016","journal-title":"Rev. Port. Cardiol."},{"issue":"11","key":"10.1016\/j.peptides.2022.170786_bib28","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1158\/0008-5472.CAN-19-2714","article-title":"FGF trapping inhibits multiple myeloma growth through c-Myc degradation-induced mitochondrial oxidative stress","volume":"80","author":"Ronca","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.peptides.2022.170786_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.redox.2016.12.024","article-title":"Fibroblast growth factor 21 and its novel association with oxidative stress","volume":"11","author":"Gomez-Samano","year":"2017","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.peptides.2022.170786_bib30","article-title":"Fibroblast growth factor 21 and its association with oxidative stress and lipid profile in type 2 diabetes mellitus","volume":"13","author":"Aleem","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.peptides.2022.170786_bib31","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.hrtlng.2020.06.001","article-title":"NOVEL antioxidant and oxidant biomarkers related to sarcopenia in COPD","volume":"50","author":"Sepulveda-Loyola","year":"2021","journal-title":"Heart Lung"},{"key":"10.1016\/j.peptides.2022.170786_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101330","article-title":"Differential contribution of Nox1, Nox2 and Nox4 to kidney vascular oxidative stress and endothelial dysfunction in obesity","volume":"28","author":"Munoz","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.peptides.2022.170786_bib33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.freeradbiomed.2018.03.053","article-title":"Up-regulation of NOX1\/NADPH oxidase following drug-induced myocardial injury promotes cardiac dysfunction and fibrosis","volume":"120","author":"Iwata","year":"2018","journal-title":"Free Radic Biol. Med."},{"issue":"7","key":"10.1016\/j.peptides.2022.170786_bib34","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00726-021-03005-8","article-title":"Alarin alleviated cardiac fibrosis via attenuating oxidative stress in heart failure rats","volume":"53","author":"Li","year":"2021","journal-title":"Amino Acids"},{"issue":"5","key":"10.1016\/j.peptides.2022.170786_bib35","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1073\/pnas.0438035100","article-title":"Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species","volume":"100","author":"Dewald","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978122000523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978122000523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:31:17Z","timestamp":1759311077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978122000523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":35,"alternative-id":["S0196978122000523"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2022.170786","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast growth factor 12 attenuated cardiac remodeling via suppressing oxidative stress","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2022.170786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170786"}}